First Month on Microdose Tirzepatide: What 57 Patients Reported
What is the average weight loss on tirzepatide in the first month at a microdose? The PlexusDx study reports what 57 patients recorded 14 to 35 days after starting 1 to 2 mg a week, including how many lost nothing. Here is the full picture, with its limits.
Standard Dose vs Microdose GLP-1: Semaglutide and Tirzepatide
Standard-dose compounded semaglutide and tirzepatide are designed for stronger, more traditional weight loss support, while microdose GLP-1 protocols offer a gentler, lower-dose approach for patients who want gradual appetite control with potentially improved tolerability.
Understanding Tirzepatide Microdosing: How Much is a Micro Dose for You?
Many people ask if 1.25 mg of tirzepatide is a microdose and whether it works. Here is what the label says, what the PlexusDx study of 60 patients found for people who started at 1 mg a week, and why the study cannot answer the 1.25 mg question directly.
What Happens If You Take Tirzepatide Twice a Week?
Taking tirzepatide twice a week is a schedule, not a dose. The label is once weekly. In the PlexusDx study, 4 of 60 patients started at 1 mg twice a week (2 mg a week total). Here is the difference between how often you inject and how much you get, and why only a prescriber should change either.
Tirzepatide Results Timeline: Week by Week Guide
A tirzepatide results timeline, week by week, from two separate sources: what 60 patients on 1 to 2 mg a week reported in the PlexusDx study at about 3, 7 and 9 weeks, and what full-dose clinical trials of the FDA-approved product reported over 72 weeks. Kept apart, on purpose.
MEDVi vs Gala GLP-1 vs PlexusDx (2026): Verified Pricing & Best Fit
MEDVi vs Gala GLP-1 vs PlexusDx compared on verified 2026 pricing, compounded vs FDA-approved status, cancellation rules, and where a genetic baseline changes the dose decision before week one.
GLP-1 Under $200 Per Month (2026): Which Options Are Real
The honest list of GLP-1 options under $200/mo in April 2026 is much shorter than the ads suggest. PlexusDx Microdose GLP-1 Protocol at $129/mo flat is the lowest under-$200 option in this comparison, with PlexusDx Semaglutide Injection at $189/mo month-to-month (or $149/mo on the 6-month plan) as the lowest weekly compounded semaglutide path. FDA-approved Foundayo and the Wegovy pill start at $149/mo at lower doses but escalate with dose; most other “$199 GLP-1” ads are first-month-only promos that jump to $249–$349 on refill.
